Participated · Equity · May 2026

Reduciner commercialises a thermochemical process that converts captured carbon dioxide into carbon monoxide using renewable electricity and biogenic carbon, producing activated carbon as a co-product. Its output carbon monoxide is compatible with existing industrial machinery, allowing companies to reduce emissions without major infrastructure changes. The technology targets emissions-intensive sectors such as lime, cement, steel, and pulp and aims to enable circular use of carbon within industrial processes. Reduciner plans pilot and demonstration projects and initial industrial deployments in Finland, with broader international expansion planned. The company recently secured €3.6 million in funding combining equity and an in-kind IP contribution from VTT to support development and commercialisation.

Participated · Equity · Apr 2026

ArgusEye develops the Auga™ platform to provide real-time monitoring for bioprocesses in biopharma manufacturing. The company aims to enable more data-driven and continuous manufacturing workflows by delivering live process insights. With the newly announced €3.3M funding round, ArgusEye intends to accelerate technology development and expand commercially into key markets. Management said the capital will help scale the platform and broaden the customer base globally. The announcement did not disclose revenue, users, or a valuation.

Led · Seed · Apr 2026

TheStorage develops a sand-based thermal energy storage system that stores and releases heat to help industrial operators electrify heat processes and integrate renewable electricity. Its technology aims to reduce energy costs and emissions compared with fossil-based heat systems while enabling participation in electricity market and grid balancing opportunities. The company emphasizes high-efficiency heat transfer and integration with existing industrial processes. TheStorage recently raised €3.6 million in a seed round to accelerate commercialisation, expand its team, and continue technology development. Leadership includes CEO and co-founder Timo Siukkola, who has cited strong industrial interest in thermal energy storage. The company plans to scale its solution globally as industries seek to decarbonise heat and improve energy flexibility.

Led · Series A · Mar 2026

Photoncycle is developing a distributed, solid-state hydrogen energy storage system that converts surplus summer solar electricity into hydrogen stored underground and later releases it as heat and power during winter. The technology is aimed at households and small businesses, closing the critical seasonal storage gap that short-duration batteries cannot solve. Photoncycle plans to offer the solution via a subscription bundle that includes solar panels, the storage unit, servicing, and access to energy-trading markets, reducing upfront costs for consumers. At full industrial scale, its proposed 1.4 TWh annual manufacturing facility could equip roughly 140,000 homes with 10 MWh of seasonal storage each. Initial commercial rollout is planned for Denmark and the Netherlands, with longer-term expansion opportunities identified in Japan and the United States. The company recently secured €15 million in Series A funding to finance these initiatives and the first phase of its industrialisation plan.

Led · Equity · Feb 2026

CubaseBio is building a next-generation 3D spatial transcriptomics platform that captures gene expression inside intact specimens through volumetric DNA microscopy. The technology reconstructs three-dimensional proximity maps by embedding molecular networks into samples and decoding them with DNA sequencing, yielding both spatial coordinates and nucleotide-level information in a single readout. By moving beyond traditional 2D tissue sections, the company aims to make spatial biology workflows scalable for drug discovery, disease research, organoid studies and whole-organism profiling. Founded in 2024 by spatial-omics veterans Malte Kuhnemund, Xiaoyan Qian, Toon Verheyen and Paulius Mielinis, the team also includes scientific advisory co-founders Joshua Weinstein and Björn Högberg, pioneers of DNA microscopy. CubaseBio plans to use its newly raised capital to advance core technology development, expand engineering capacity and initiate early commercialization efforts. Financially, the company has secured €5.9 million in blended funding, its first external capital, providing runway to refine the platform and engage pilot customers. No user, revenue or deployment metrics have been disclosed yet.